FGFR1 and osteosarcoma: In this study, we found that sulfatinib inhibits the phosphorylation of FGFR1, and downstream kinases in osteosarcoma cells play key roles in the inhibition of proliferation, promoting apoptosis and enhancing chemo-sensitivity.